AN Hongsa,RONG Xinqian,YANG Weifeng,et al.Effects and mechanisms of Veronica linariifolia in inhibiting MRSA drug-resistant biofilms[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(10):1285-1291.
AN Hongsa,RONG Xinqian,YANG Weifeng,et al.Effects and mechanisms of Veronica linariifolia in inhibiting MRSA drug-resistant biofilms[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(10):1285-1291. DOI: 10.16025/j.1674-1307.2025.10.011.
Effects and mechanisms of Veronica linariifolia in inhibiting MRSA drug-resistant biofilms
To investigate the inhibitory effects and underlying mechanisms of the Chinese medicinal material
Veronica linariifolia
(Lemahui, LMH) on methicillin-resistant
Staphylococcus aureus
(MRSA) drug-resistant biofilms.
Methods
2
MRSA was cultured to form mature drug-resistant biofilms, which were then treated with LMH injection. The ultrastructure of the biofilms was observed using scanning electron microscopy (SEM). Based on literature review and database retrieval, the main active components of LMH and genes associated with biofilm drug resistance were identified. The 3D structures of the active compounds and the corresponding biofilm drug-resistance targets were obtained from the SwissTargetPrediction and UniProt databases. Cytoscape software was used to construct the component-target interaction network of LMH. A protein-protein interaction (PPI) network was established using the STRING database. Molecular docking between key active compounds and core targets was performed using AutoDock Vina, followed by 100 ns molecular dynamics (MD) simulations with Gromacs 2022 to screen effective components and genes. Finally, reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to validate the effects of LMH and its major active components on the expression of core genes related to biofilm formation and drug resistance.
Results
2
LMH inhibited MRSA biofilm formation. Its main constituents, protocatechuic acid (PCA) and salicylic acid (SA), bound tightly to the core targets of MRSA drug-resistant biofilms SarA, SarX, Rot, and SigB, with binding energies below -4.5 kcal/mol. Molecular dynamics simulations indicated overall structural stability of these complexes. RT-qPCR showed that LMH significantly downregulated the expression of these core regulatory genes.
Conclusion
2
LMH inhibits the formation of MRSA drug-resistant biofilms. Its mechanisms may involve multi-target synergistic modulation by PCA and SA, which interfere with biofilm-associated regulatory networks and downregulate the expression of key regulatory genes.
关键词
Keywords
references
TURNER NA , SHARMA-KUINKEL BK , MASKARINEC SA , et al . Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research [J ] . Nat Rev Microbiol , 2019 , 17 ( 4 ): 203 - 218 .
LEBEAUX D , GHIGO JM , BELOIN C . Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics [J ] . Microbiol Mol Biol Rev , 2014 , 78 ( 3 ): 510 - 543 .
ROY R , TIWARI M , DONELLI G , et al . Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action [J ] . Virulence , 2018 , 9 ( 1 ): 522 - 554 .
ZHOU H , WANG W , CAI L , et al . Potentiation and mechanism of berberine as an antibiotic adjuvant against multidrug-resistant bacteria [J ] . Infect Drug Resist , 2023 , 16 : 7313 - 7326 .
MOHANTY M , MOHANTY PS . Molecular docking in organic, inorganic, and hybrid systems: a tutorial review [J ] . Monatsh Chem , 2023 : 1 - 25 .
MARK P , NILSSON L . Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298K [J ] . J Phys Chem A , 2001 , 105 ( 43 ): 9954 - 9960 .
HERNÁNDEZ-CUELLAR E , TSUCHIYA K , VALLE-RÍOS R , et al . Differences in biofilm formation by methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains [J ] . Diseases , 2023 , 11 ( 4 ): 160 .
LI LL , CHEUNG A , BAYER AS , et al . The global regulon sara regulates β-lactam antibiotic resistance in methicillin-resistant Staphylococcus aureus in vitro and in endovascular infections [J ] . Diseases , 2016 , 214 ( 9 ): 1421 - 1429 .
XIAO Y , WAN C , WU X , et al . Novel small-molecule compound YH7 inhibits the biofilm formation of Staphylococcus aureus in a sarX-dependent manner [J ] . mSphere , 2024 , 9 ( 1 ): e0056423 .
MOOTZ JM , BENSON MA , HEIM CE , et al . Rot is a key regulator of Staphylococcus aureus biofilm formation [J ] . Mol Microbiol , 2015 , 96 ( 2 ): 388 - 404 .
JALALI O , BEST M , WONG A , et al . Protocatechuic acid as a topical antimicrobial for surgical skin antisepsis: preclinical investigations [J ] . JB JS Open Access , 2020 , 5 ( 3 ): e19 .
LIU K , TSAO S , YIN M . In vitro antibacterial activity of roselle calyx and protocatechuic acid [J ] . Phytother Res , 2005 , 19 ( 11 ): 942 - 945 .
AHMED HA , EL-MARADNY YA , SHALABY MA , et al . Isolation and characterization of chitosan from shrimp shell waste and the sustainable preparation of salicylic acid-loaded chitosan nanoparticles for antibiofilm applications [J ] . Sci Rep , 2025 , 15 ( 1 ): 19263 .
PALMA M , BAYER A , KUPFERWASSER LI , et al . Salicylic acid activates sigma factor B by rsbU-dependent and -independent mechanisms [J ] . J Bacteriol , 2006 , 188 ( 16 ): 5896 - 5903 .
SYKES E , WHITE D , MCLAUGHLIN S , et al . Salicylic acids and pathogenic bacteria: new perspectives on an old compound [J ] . Can J Microbiol , 2024 , 70 ( 1 ): 1 - 14 .
Mechanism of Ganlu Xiaodu Dan's intervention in influenza A virus infection by regulating PI3K/Akt signaling pathway
Mechanism of Zizao Yangrong Formula in treating skin xerosis caused by anti-cancer targeted drugs
Mechanism of Jianpi Shugan Guben Formula for diarrhea-predominant irritable bowel syndrome based on network pharmacology and animal experiment
Exploring the potential mechanism of Jianpi Qinghua Huayu Decoction in the treatment of precancerous lesions of gastric cancer based on network pharmacology combined with GEO chip analysis and molecular docking technology
Mechanism ofBanxia Xiexin Decoction in treating chronic atrophic gastritis by integrated pharmacology
Related Author
WANG Chengxiang
YU Huiyong
LYU Siyuan
ZHANG Yue
ZHAO Ronghua
GUO Shanshan
HUANG Tingxuan
SHI Yanan
Related Institution
Respiratory Department, the Third Affiliated Hospital of Beijing University of Chinese Medicine
Biosecurity Laboratory, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Department of Respiratory and Critical Care Medicine, Dongzhimen Hospital Xiamen Hospital, Beijing University of Chinese Medicine
Department of Integrative Oncology, China-Japan Friendship Hospital
Graduate School, Beijing University of Chinese Medicine